Atlas Trials

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Clinical trial NCT05327127 · COMPLETED

Trial details

NCT number
NCT05327127
Sponsor
Kowa Research Institute, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NASH
Start date
2022-11-14
Primary completion
2026-05-20
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.